Intranasal nanocrystals of tadalafil: in vitro characterisation and in vivo pharmacokinetic study
Tadalafil (TDA) is a class II drug of the biopharmaceuticals classification system (BCS), with limited aqueous solubility and high permeability. This study aims to improve the bioavailability of poorly soluble tadalafil by developing intranasal nanocrystals (NCs) of TDA. TDA NCs that were stabilised...
Saved in:
Main Authors: | Ruba S. Darweesh (Author), Lubna A. Shriem (Author), Nusaiba K. Al-Nemrawi (Author) |
---|---|
Format: | Book |
Published: |
Pensoft Publishers,
2024-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Coating methotrexate-PLGA nanoparticles with folic acid-chitosan conjugate for cancer targeting
by: Nusaiba Al-Nemrawi, et al.
Published: (2024) -
Enhanced Bioavailability of Tadalafil after Intranasal Administration in Beagle Dogs
by: Jeong-Soo Kim, et al.
Published: (2018) -
In vitro/vivo assessment of praziquantel nanocrystals: Formulation, characterization, and pharmacokinetics in beagle dogs
by: Ruyi Yang, et al.
Published: (2019) -
Intranasal delivery of paeoniflorin nanocrystals for brain targeting
by: Chaoyin Wu, et al.
Published: (2020) -
Effects of Experimental Hyperlipidemia on the Pharmacokinetics of Tadalafil in Rats
by: Joo Hyun Lee, et al.
Published: (2012)